• Ticker

    Advertisement
DJIA 12,801.23 -89.23 -0.69%
NASDAQ 2,903.88 -23.35 -0.80%
S&P 500 1,342.64 -9.31 -0.69%
Maintenance Notification

Quotes and Portfolios will be down on Sunday February 12, 2012 from 2 AM to 4 AM while we perform maintenance on the site. We apologize for the inconvenience.

$0.35 -$0.01 (-2.78%)

Quote as of 3:49 PM EST on 02/10/12

NORTHWEST BIOTHRPUTCS INC

NASDAQOTCBB:NWBO.OB

Jump to this page for:

Related Resources

Northwest Biotherapeutics requests withdrawal of registration statement

1/10/2012 by Theflyonthewall.com

NW Bio to Present Today at the OneMedForum SF 2012 Conference

1/10/2012 by PR Newswire

NW Bio Reaches 25 Clinical Trial Sites Open and Recruiting By the End of Q4, 2011

1/9/2012 by PR Newswire

Northwest Biotherapeutics (NWBO): Initiating with an Outperform Rating - Analyst Blog

12/13/2011 by Zacks Investment Research

Northwest Biotherapeutics (NWBO): Initiating with an Outperform Rating

12/13/2011 by Zacks Equity Research Analyst Blog

Northwest Bio Implements Major Balance Sheet Clean-Up

12/2/2011 by PR Newswire

Northwest Bio Announces Transactions for $5.4 Million in New Financing

11/17/2011 by PR Newswire

Northwest Bio to Present at Society of Neuro-Oncology Annual Meeting

11/15/2011 by PR Newswire

Northwest Bio Announces Interview of CEO Linda Powers in Today's CEO/CFO Publication

11/1/2011 by PR Newswire

Standard & Poor's Initiates Factual Stock Report Coverage on Northwest Biotherapeutics, Inc.

10/25/2011 by StockWatch

NORTHWEST BIO Announces Initiation of S&P Coverage, With Publication of First Company Stock Report

10/25/2011 by PR Newswire

NORTHWEST BIO Announces Positive Third Quarter Progress

10/6/2011 by PR Newswire

NWBT Highlights Cost Effectiveness of DCVax® in View of Recent Immunotherapy Pricing Concerns

8/10/2011 by PR Newswire

NWBT Announces Further Expansion of Clincal Sites in Ongoing Brain Cancer Trial

8/4/2011 by PR Newswire

Key investments should continue to propel Northwest Biotherapeutics (NAB,NAS:NWBO,DNDN)

7/11/2011 by AccessWire

"Growing Momentum and Recognition" for Northwest Biotherapeutics Should Continue

7/11/2011 by Marketwire

Family Foundation of Business Leader Invests $4.55 Million in Northwest Biotherapeutics for Promising Clinical Trials in the US and Europe

7/8/2011 by PharmiWeb.com - UK

Northwest Biotherapeutics announces $4.55M equity investment

7/8/2011 by Theflyonthewall.com

Family Foundation of Business Leader Invests $4.55 Million in Northwest Biotherapeutics for Promising Clinical Trials in the US and Europe

7/8/2011 by PR Newswire

Northwest Biotherapeutics names new CEO, COO

6/9/2011 by Washington Business Journal - Washington DC

Northwest Biotherapeutics Announces Change and Expansion of Management Team

6/9/2011 by PR Newswire

Northwest Biotherapeutics Announces Change and Expansion of Management Team

6/9/2011 by PharmiWeb.com - UK

Northwest Biotherapeutics lands funding

6/6/2011 by Washington Business Journal - Washington DC

Northwest Biotherapeutics Announces Series of Financing Arrangements

6/6/2011 by PharmiWeb.com - UK

Northwest Biotherapeutics Announces Series of Financing Arrangements

6/5/2011 by StockWatch

Northwest Biotherapeutics Announces Series of Financing Arrangements

6/5/2011 by PR Newswire

Investing in Cancer Therapy? Consider Companies Engaged in Immunotherapy

6/1/2011 by Seeking Alpha

Northwest Biotherapeutics Further Expands Ongoing Brain Cancer Trial

5/30/2011 by Biocompare

Northwest Biotherapeutics adds new clinical sites for brain cancer trial

5/27/2011 by Datamonitor

Northwest Biotherapeutics Further Expands Ongoing Brain Cancer Trial

5/27/2011 by Medical News Today - UK

Northwest Biotherapeutics Further Expands Ongoing Brain Cancer Trial

5/26/2011 by PharmiWeb.com - UK

Northwest Biotherapeutics Further Expands Ongoing Brain Cancer Trial

5/25/2011 by StockWatch

Northwest Biotherapeutics to Present at American Society of Cell and Gene Therapy

5/21/2011 by Biocompare

Northwest Biotherapeutics and the Fraunhofer Institute for Cell Therapy and Immunology Are Partnering for Clinical Trials and Compassionate Use Cases in Europe

5/18/2011 by PharmiWeb.com - UK

Northwest Biotherapeutics' Ongoing Brain Cancer Trial Recruiting Additional Patients at Four Medical Centers Across US

5/3/2011 by StockWatch

Report: Northwest Biotherapeutics Won't Be Staying Under the Radar for Long

4/28/2011 by Marketwire

Trade Alerts Issued for TapImmune and Northwest Biotherapeutics

4/4/2011 by Marketwire

Northwest Biotherapeutics Launches Public Information Campaign in Collaboration with the Money Channel

3/29/2011 by Pharmaceutical and Medical Packaging News

Northwest Biotherapeutics Addresses Recent Market Activity

3/16/2011 by StockWatch

Northwest Biotherapeutics Addresses Recent Market Activity

3/16/2011 by StockHouse
See More Articles...